Medscape | Spironolactone Reduces Heart Failure Hospitalizations, but Not Mortality ... Science Daily (press release) 18, 2013 — A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013 ... AHA: Decision on Spironolactone in HF a Toss-Up? Aldo-Antagonist Falls Short but Impresses in Preserved-EF Heart Failure: TOPCAT |
